Skip to content
Using human cells engineered to create the world’s first 3D spinal cord tissues, scientists repaired the spinal cords of injured mice, offering the promise […]
Spinal cord implants provide hope of walking again Read More »
Sepsis is a potentially fatal syndrome that occurs when the body’s reaction to infection causes damage to its own tissues and organs. And sepsis
Sepsis: Millions die and survivors face physical, emotional challenges Read More »
President Biden on Feb. 2 relaunched the “Cancer Moonshot,” which he had launched when he was vice president. The goal now is to “reduce
Biden’s Cancer Moonshot aims to reduce death rate by 50% Read More »
An innovative cell-based gene therapy implemented almost a decade ago not only eradicated cancer in a pair of chronic lymphocytic leukemia patients, it also
Genetically engineered T cells remain in leukemia patients long after remission Read More »
Reports this week of deer in Staten Island becoming the first wild animals identified as having the Omicron variant of the coronavirus underline the
One Health treats human, animal, and ecosystem health together Read More »
Moderna announced the launch of a clinical trial of an HIV vaccine using the same mRNA technology that has allowed for quick and effective
Moderna tests mRNA HIV vaccine – as virulent new strain appears Read More »
A new study investigates the benefits of extrapolating results from clinical trials involving adults to make conclusions about how the drugs will impact children.
Can we extrapolate adult clinical trials to benefit pediatric medicine? Read More »
When the LA Rams and Cincinnati Bengals meet for the Super Bowl on Feb. 13, America’s attention will be focused on the action taking
Super Bowl gets the hype, but football’s link to CTE deserves a look Read More »
The microplastic pollution caused by the broken-down styrofoam containers—yes, that discarded package that held your hamburger—may significantly contribute to the growing resistance to antibiotics
Study finds microplastic pollution worsens threat of antibiotic resistance Read More »
SAB Biotherapeutics, a clinical-stage biopharmaceutical company with a novel immunotherapy platform, announced on Jan. 24 that its SAB-185 antibody candidate for COVID-19 treatment has
SAB Biotherapeutics’ COVID-19 antibody OK’d for Phase 3 trial Read More »
